133 related articles for article (PubMed ID: 37424832)
1. Spectrometric Analysis of Dantrolene Sodium.
Isaacs JT; Almeter PJ; Henderson BS; Hunter AN; Platt TL; McGuire C; Lodder RA
Contact Context; 2023; 2023():. PubMed ID: 37424832
[TBL] [Abstract][Full Text] [Related]
2. Spectrometric Analysis of Process Variations in Remifentanil.
Isaacs JT; Almeter PJ; Henderson BS; Hunter AN; Platt TL; Lodder RA
Contact Context; 2022; 2022():. PubMed ID: 36187755
[TBL] [Abstract][Full Text] [Related]
3. FTNIR Spectrometry of Micafungin Sodium Quality.
Isaacs JT; Almeter PJ; Henderson BS; Hunter AN; Platt TL; Lodder RA
Contact Context; 2022; 2022():. PubMed ID: 35360460
[TBL] [Abstract][Full Text] [Related]
4. Variability in Content of Piperacillin and Tazobactam Injection.
Isaacs JT; Almeter PJ; Henderson BS; Hunter AN; Platt TL; Lodder RA
Contact Context; 2022; 2022():. PubMed ID: 35506061
[TBL] [Abstract][Full Text] [Related]
5. Potential Process Control Issues with Pemetrexed.
Isaacs JT; Almeter PJ; Henderson BS; Hunter AN; Platt TL; Lodder RA
Contact Context; 2022; 2022():. PubMed ID: 35967958
[TBL] [Abstract][Full Text] [Related]
6. Spectral Intra-Lot and Inter-Lot Variability in Carfilzomib.
Isaacs JT; Almeter PJ; Henderson BS; Hunter AN; Platt TL; Anwar H; Lodder RA
Contact Context; 2023; 2023():. PubMed ID: 37008539
[TBL] [Abstract][Full Text] [Related]
7. Lack of Content Uniformity in MMR Vaccine.
Isaacs JT; Almeter PJ; Henderson BS; Hunter AN; Platt TL; Lodder RA
Contact Context; 2022; 2022():. PubMed ID: 35360461
[TBL] [Abstract][Full Text] [Related]
8. Spectrometric Results of Process Variations in Dacarbazine.
Isaacs JT; Almeter PJ; Henderson BS; Hunter AN; Platt TL; Lodder RA
Contact Context; 2022; 2022():. PubMed ID: 35035310
[TBL] [Abstract][Full Text] [Related]
9. Levothyroxine Variations by Process Analytical Technology.
Isaacs JT; Almeter PJ; Henderson BS; Hunter AN; Platt TL; Lodder RA
Contact Context; 2022; 2022():. PubMed ID: 35440917
[TBL] [Abstract][Full Text] [Related]
10. Intra-Lot and Inter-Lot Variability in Cosyntropin.
Almeter PJ; Isaacs JT; Hunter AN; Henderson BS; Lodder RA
Contact Context; 2021; 2021():. PubMed ID: 35035309
[TBL] [Abstract][Full Text] [Related]
11. Intra-Lot and Inter-Lot Variability in Ceftaroline Fosamil.
Almeter PJ; Isaacs JT; Hunter AN; Henderson BS; Lodder RA
Contact Context; 2021; 2021():. PubMed ID: 35360663
[TBL] [Abstract][Full Text] [Related]
12. Quality Variations in Thyrotropin Alfa.
Isaacs JT; Almeter PJ; Henderson BS; Hunter AN; Platt TL; Samano-Garcia C; Lodder RA
Contact Context; 2023; 2023():. PubMed ID: 37396298
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the therapeutic effectiveness of a dantrolene sodium solution and a novel nanocrystalline suspension of dantrolene sodium in malignant hyperthermia normal and susceptible pigs.
Schütte JK; Becker S; Burmester S; Starosse A; Lenz D; Kröner L; Wappler F; Gerbershagen MU
Eur J Anaesthesiol; 2011 Apr; 28(4):256-64. PubMed ID: 21513076
[TBL] [Abstract][Full Text] [Related]
14. Application of Near-Infrared Spectroscopy for Screening of Chlorothiazide Sodium Vials.
Isaacs JT; Almeter PJ; Hunter AN; Lyman TA; Zapata SP; Henderson BS; Larkin SA; Long LM; Bossle MN; Bhaktawara SA; Warren MF; Lozier AM; Melson JD; Fraley SR; Relucio EHL; Felix MA; Reynolds JW; Naseman RW; Platt TL; Lodder RA
Contact Context; 2024; 2024():. PubMed ID: 38774605
[TBL] [Abstract][Full Text] [Related]
15. Availability of dantrolene for the management of malignant hyperthermia crises: European Malignant Hyperthermia Group guidelines.
Glahn KPE; Bendixen D; Girard T; Hopkins PM; Johannsen S; Rüffert H; Snoeck MM; Urwyler A;
Br J Anaesth; 2020 Aug; 125(2):133-140. PubMed ID: 32591088
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacological Treatment of Malignant Hyperthermia: Update 2019].
Schuster F; Johannsen S
Anasthesiol Intensivmed Notfallmed Schmerzther; 2019 Sep; 54(9):549-558. PubMed ID: 31525788
[TBL] [Abstract][Full Text] [Related]
17. 3,4-Methylenedioxymethamphetamine induces a hyperthermic and hypermetabolic crisis in pigs with and without a genetic disposition for malignant hyperthermia.
Schütte JK; Schäfer U; Becker S; Oldewurtel C; Starosse A; Singler P; Richard A; Wappler F; Gerbershagen MU
Eur J Anaesthesiol; 2013 Jan; 30(1):29-37. PubMed ID: 23138574
[TBL] [Abstract][Full Text] [Related]
18. Dantrolene sodium is able to reduce the resting ionic [Ca2+]i in muscle from humans with malignant hyperthermia.
López JR; Medina P; Alamo L
Muscle Nerve; 1987 Jan; 10(1):77-9. PubMed ID: 3561441
[TBL] [Abstract][Full Text] [Related]
19. Effects of azumolene on normal and malignant hyperthermia-susceptible skeletal muscle.
Sudo RT; Carmo PL; Trachez MM; Zapata-Sudo G
Basic Clin Pharmacol Toxicol; 2008 Mar; 102(3):308-16. PubMed ID: 18047479
[TBL] [Abstract][Full Text] [Related]
20. Dantrolene sodium fails to reverse robust brain hyperthermia induced by MDMA and methamphetamine in rats.
Cameron-Burr KT; Bola RA; Kiyatkin EA
Psychopharmacology (Berl); 2023 Apr; 240(4):785-795. PubMed ID: 36700960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
